406 related articles for article (PubMed ID: 31980686)
1. Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles.
Lima T; Bernfur K; Vilanova M; Cedervall T
Sci Rep; 2020 Jan; 10(1):1129. PubMed ID: 31980686
[TBL] [Abstract][Full Text] [Related]
2. In Situ Characterization of Protein Adsorption onto Nanoparticles by Fluorescence Correlation Spectroscopy.
Shang L; Nienhaus GU
Acc Chem Res; 2017 Feb; 50(2):387-395. PubMed ID: 28145686
[TBL] [Abstract][Full Text] [Related]
3. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
Kopac T
Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
[TBL] [Abstract][Full Text] [Related]
4. Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties.
Liu R; Jiang W; Walkey CD; Chan WC; Cohen Y
Nanoscale; 2015 Jun; 7(21):9664-75. PubMed ID: 25959034
[TBL] [Abstract][Full Text] [Related]
5. Concentration-dependent protein adsorption at the nano-bio interfaces of polymeric nanoparticles and serum proteins.
Zhang TX; Zhu GY; Lu BY; Zhang CL; Peng Q
Nanomedicine (Lond); 2017 Nov; 12(22):2757-2769. PubMed ID: 29017387
[TBL] [Abstract][Full Text] [Related]
6. Disease-related metabolites affect protein-nanoparticle interactions.
Tavakol M; Montazeri A; Naghdabadi R; Hajipour MJ; Zanganeh S; Caracciolo G; Mahmoudi M
Nanoscale; 2018 Apr; 10(15):7108-7115. PubMed ID: 29616243
[TBL] [Abstract][Full Text] [Related]
7. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
8. Uptake of polymeric nanoparticles in a human induced pluripotent stem cell-based blood-brain barrier model: Impact of size, material, and protein corona.
Onyema HN; Berger M; Musyanovych A; Bantz C; Maskos M; Freese C
Biointerphases; 2021 Mar; 16(2):021004. PubMed ID: 33765771
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes.
Fleischer CC; Payne CK
Acc Chem Res; 2014 Aug; 47(8):2651-9. PubMed ID: 25014679
[TBL] [Abstract][Full Text] [Related]
10. Biological effects of formation of protein corona onto nanoparticles.
Mishra RK; Ahmad A; Vyawahare A; Alam P; Khan TH; Khan R
Int J Biol Macromol; 2021 Apr; 175():1-18. PubMed ID: 33508360
[TBL] [Abstract][Full Text] [Related]
11. Effect of nanoparticle size and PEGylation on the protein corona of PLGA nanoparticles.
Partikel K; Korte R; Stein NC; Mulac D; Herrmann FC; Humpf HU; Langer K
Eur J Pharm Biopharm; 2019 Aug; 141():70-80. PubMed ID: 31082511
[TBL] [Abstract][Full Text] [Related]
12. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
[TBL] [Abstract][Full Text] [Related]
13. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
[TBL] [Abstract][Full Text] [Related]
14. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
[TBL] [Abstract][Full Text] [Related]
15. Plasma proteins facilitates placental transfer of polystyrene particles.
Gruber MM; Hirschmugl B; Berger N; Holter M; Radulović S; Leitinger G; Liesinger L; Berghold A; Roblegg E; Birner-Gruenberger R; Bjelic-Radisic V; Wadsack C
J Nanobiotechnology; 2020 Sep; 18(1):128. PubMed ID: 32907583
[TBL] [Abstract][Full Text] [Related]
16. Complete high-density lipoproteins in nanoparticle corona.
Hellstrand E; Lynch I; Andersson A; Drakenberg T; Dahlbäck B; Dawson KA; Linse S; Cedervall T
FEBS J; 2009 Jun; 276(12):3372-81. PubMed ID: 19438706
[TBL] [Abstract][Full Text] [Related]
17. Bacterial endotoxin (lipopolysaccharide) binds to the surface of gold nanoparticles, interferes with biocorona formation and induces human monocyte inflammatory activation.
Li Y; Shi Z; Radauer-Preiml I; Andosch A; Casals E; Luetz-Meindl U; Cobaleda M; Lin Z; Jaberi-Douraki M; Italiani P; Horejs-Hoeck J; Himly M; Monteiro-Riviere NA; Duschl A; Puntes VF; Boraschi D
Nanotoxicology; 2017; 11(9-10):1157-1175. PubMed ID: 29192556
[TBL] [Abstract][Full Text] [Related]
18. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
[TBL] [Abstract][Full Text] [Related]
19. Formation of a Monolayer Protein Corona around Polystyrene Nanoparticles and Implications for Nanoparticle Agglomeration.
Wang H; Ma R; Nienhaus K; Nienhaus GU
Small; 2019 May; 15(22):e1900974. PubMed ID: 31021510
[TBL] [Abstract][Full Text] [Related]
20. Protein Corona Mediated Uptake and Cytotoxicity of Silver Nanoparticles in Mouse Embryonic Fibroblast.
Barbalinardo M; Caicci F; Cavallini M; Gentili D
Small; 2018 Aug; 14(34):e1801219. PubMed ID: 30058105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
